Activation of the mTOR pathway by low levels of xenoestrogens in breast epithelial cells from high-risk women

Breast cancer is an estrogen-driven disease. Consequently, hormone replacement therapy correlates with disease incidence. However, increasing male breast cancer rates over the past three decades implicate additional sources of estrogenic exposure including wide spread estrogen-mimicking chemicals or...

Descripción completa

Detalles Bibliográficos
Autores principales: Goodson, William H., Luciani, Maria Gloria, Sayeed, S. Aejaz, Jaffee, Ian M., Moore, Dan H., Dairkee, Shanaz H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Carcinogenesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204351/
https://www.ncbi.nlm.nih.gov/pubmed/21890461
http://dx.doi.org/10.1093/carcin/bgr196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204351/
https://www.ncbi.nlm.nih.gov/pubmed/21890461
http://dx.doi.org/10.1093/carcin/bgr196

Ejemplares similares